Tiago Biachi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma (NCT04054518) | Tiago Biachi | 2019-10-01 |
Track Tiago Biachi automatically
Every clearance here is in the API, with alerts when new ones post.